SiliconInvestor
     Advanced Search   [ sign in ]

register
Sponsor		  register
Register

 Biotech / Medical | biotech fireworks

Previous 10 | Next 10 
To: tuck who wrote (5427)8/4/2010 11:54:07 AM
From: tuck   of 6109
 
Dendreon (DNDN) 18% following earnings. As the launch of Provenge is in its early stages, I doubt it was the actual eps # that is causing this, rather some color on the intermediate term future of the launch. Haven't looked under the hood.

Cheers, Tuck

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)

To: nigel bates who wrote (5109)8/4/2010 12:46:15 PM
From: tuck   of 6109
 
DepoMed (DEPO) 17% on news:

>>MENLO PARK, Calif., Aug. 3, 2010 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO - News) today announced that pursuant to the Hatch-Waxman Act, the 45-day period for filing a patent infringement suit under the Act, and thus initiating a 30-month stay on the FDA's ability to approve the DM-1796 NDA, has expired. Depomed has confirmed with Pfizer Inc. that no suit under the Act has been filed. DM-1796 is an extended release, once-daily tablet formulation of gabapentin for post-herpetic neuralgia developed by Depomed.

"We look forward to a potential approval of DM-1796 in the first quarter of next year," commented Carl A. Pelzel, Depomed's president and chief executive officer.<<

snip

Cheers, Tuck

Share Recommend | Keep | Reply | Mark as Last Read

From: Dave O.8/5/2010 11:45:13 AM
   of 6109
 
AFFY up 17% on Takeda announcement today

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)

To: Jibacoa who wrote (5443)8/9/2010 11:39:49 AM
From: Jibacoa   of 6109
 
PPCO was up 16.15% but is up only 9.26% at present.

Message 26741546

Bernard

Share Recommend | Keep | Reply | Mark as Last Read

From: fred hayes8/9/2010 3:42:18 PM
   of 6109
 
GENT up 16 percent. Owned this in the olden days but sold for almost nothing, as I recall...(:<)

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)

To: fred hayes who wrote (5527)8/10/2010 12:25:00 PM
From: Jibacoa   of 6109
 
Re: GENT

In February, GENT received an initial payment of EUR 5.11M ($7.0M) from Sigma-Tau in connection with amending the existing license and supply agreement to include the commercialization of the prevention of Defibrotide in North America, Central America and South America.

As of March 31, its cash position was about 4x its cash as of Dec.31.<g>

Message 26741737

Bernard

Share Recommend | Keep | Reply | Mark as Last Read

From: Ian@SI9/1/2010 4:22:00 PM
   of 6109
 
CRME up about 20% AH after trading halt lifted (PR for European Vernakalant approval posted on CRME thread)]

Sep. 1, 2010 Market Close: $ 6.19
After Hours Last: $ 7.32
Net / % Change 1.13 (18.26%)
After Hours High: $ 7.51
After Hours Volume: 28,600
After Hours Low: $ 6.64

Share Recommend | Keep | Reply | Mark as Last Read

From: fred hayes9/2/2010 9:32:11 AM
   of 6109
 
orex over 25 percent on deal.

Share Recommend | Keep | Reply | Mark as Last Read

To: Steve Lokness who wrote (5149)9/8/2010 2:29:57 PM
From: tuck   of 6109
 
ZGEN almost 85% on takeover by BMY; Cerus (CERS) ~16% on speculation it can play in the blood purification market by taking XMRV out of the supply. XMRV a putative cause of chronic fatigue syndrome. The question, can the competition also do this? I have no answer, don't follow the company.

Cheers, Tuck

Share Recommend | Keep | Reply | Mark as Last Read

To: Jim Bryan who wrote (5444)9/13/2010 3:48:16 PM
From: Jim Bryan   of 6109
 
FURX Furiex Pharmaceuticals up 15% on 5x adv

Furiex Pharmaceuticals, Inc. is scheduled to present at Rodman & Renshaw's 12th Annual Healthcare Conference in New York on Monday, September 13, 2010, at approximately 2:50 p.m., ET

Share Recommend | Keep | Reply | Mark as Last Read
Previous 10 | Next 10 

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQ
Copyright © 1995-2013 Knight Sac Media. All rights reserved.